Cargando…
Additional benefit of induced pluripotent stem cell-derived mesenchymal stem cell therapy on sepsis syndrome-associated acute kidney injury in rat treated with antibiotic
BACKGROUND: This study tested whether human induced-pluripotent stem-cell-derived mesenchymal-stem-cells (iPS-MSCs) would offer an additional benefit to the rodent with acute kidney injury (AKI) (ischemia for 1 h followed by reperfusion for 120 h) associated sepsis syndrome (SS) (by cecal-ligation-p...
Autores principales: | Yang, Chih-Chao, Sung, Pei‐Hsun, Chen, Chih-Hung, Chiang, John Y., Shao, Pei-Lin, Wu, Shun-Cheng, Yip, Hon‐Kan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8499569/ https://www.ncbi.nlm.nih.gov/pubmed/34620235 http://dx.doi.org/10.1186/s13287-021-02582-5 |
Ejemplares similares
-
Dose-dependent benefits of iron-magnetic nanoparticle-coated human umbilical-derived mesenchymal stem cell treatment in rat intracranial hemorrhage model
por: Chen, Kuan-Hung, et al.
Publicado: (2022) -
Double overexpression of miR-19a and miR-20a in induced pluripotent stem cell-derived mesenchymal stem cells effectively preserves the left ventricular function in dilated cardiomyopathic rat
por: Sheu, Jiunn-Jye, et al.
Publicado: (2021) -
Combination therapy of exendin-4 and allogenic adipose-derived mesenchymal stem cell preserved renal function in a chronic kidney disease and sepsis syndrome setting in rats
por: Chen, Chih-Hung, et al.
Publicado: (2017) -
Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury
por: Ko, Sheung-Fat, et al.
Publicado: (2023) -
Effective protection against acute respiratory distress syndrome/sepsis injury by combined adipose-derived mesenchymal stem cells and preactivated disaggregated platelets
por: Chen, Chih-Hung, et al.
Publicado: (2017)